| [1] |
Li J，Mulatibieke A，Liu S，et al. M-type phospholipase A2 receptor autoantibody measured by ELISA has diagnostic value in patients with idiopathic membranous nephropathy [J]. Clin Lab，2023，69（6）： doi 10.7754/Clin.Lab.2022.220832.
|
| [2] |
Suthar KS，Vanikar AV，Patel RD，et al. Anti-phospholipase A2 receptor antibody in differentiation and prognostication of membranous nephropathy [J]. Saudi J Kidney Dis Transpl，2022，33（2）：280-287.
|
| [3] |
Chen R，Wang J，Xie QH，et al. Favorable outcome in PLA2R positive HBV-associated membranous nephropathy [J]. BMC Nephrol，2022，23（1）：246.
|
| [4] |
Wang R，Wu Y，Zheng B，et al. Clinicopathological characteristics and prognosis of hepatitis B-associated membranousnephropathyandidiopathicmembranous nephropathy complicated with hepatitis B virus infection [J]. Sci Rep，2021，11（1）：18407.
|
| [5] |
Yu F，Li G，Hao W，et al. Hepatitis B virus-related glomerulonephritis with positive and negative serum HBsAg：different clinicopathologic characteristics of two clinical subtypes[J]. Int J Gen Med，2021，14：3069-3077.
|
| [6] |
Nikolopoulou A，Teixeira C，Cook HT，et al. Membranous nephropathy associated with viral infection [J]. Clin Kidney J，2020，14（3）：876-883.
|
| [7] |
Kupin WL. Viral-associated GN： hepatitis B and other viral infections [J]. Clin J Am Soc Nephrol，2017，12（9）：1529-1533.
|
| [8] |
梁小雨，米杰. 磷脂酶A2 受体相关特发性膜性肾病研究进展[J/CD]. 中华肾病研究电子杂志，2022，11（1）：52-56.
|
| [9] |
Dong HR，Wang YY，Cheng XH，et al. Retrospective study of phospholipase A2 receptor and IgG subclasses in glomerular deposits in Chinese patients with membranous nephropathy [J].PLoS One，2016，11（5）： e0156263.
|
| [10] |
Xie QH，Li Y，Xue J，et al. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy [J]. Am J Nephrol，2015，41（4-5）：345-353.
|
| [11] |
Safar-Boueri L，Piya A，Beck LH Jr，et al. Membranous nephropathy： diagnosis，treatment，and monitoring in the post-PLA2R era [J]. Pediatr Nephrol，2021，36（1）：19-30.
|
| [12] |
Ronco P，Debiec H. Pathophysiological advances in membranous nephropathy： time for a shift in patient's care [J]. Lancet，2015，385（9981）：1983-1992.
|
| [13] |
Maifata SM，Hod R，Zakaria F，et al. Role of serum and urine biomarkers （PLA2R and THSD7A） in diagnosis，monitoring and prognostication of primary membranous glomerulonephritis [J].Biomolecules，2020，10（2）：319.
|
| [14] |
戴沛霖，杨悦，涂天琪，等. 乙型肝炎病毒相关膜性肾病患者抗血清磷脂酶A2 受体-IgG 特点及其相关因素的临床研究[J/CD]. 中华肾病研究电子杂志，2019，08（4）：159-162.
|
| [15] |
Feng M，Yu Y，Chen Y，et al. HBx-induced PLA2R overexpression mediates podocyte pyroptosis through the ROSNLRP3 signaling pathway [J]. Ren Fail，2023，45 （1）：2170808.
|
| [16] |
Hoxha E，Harendza S，Zahner G，et al. An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis [J].Nephrol Dial Transplant，2011，26（8）：2526-2532.
|
| [17] |
Takekoshi Y，Tochimaru H，Nagata Y，et al.Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy [J]. Kidney Int Suppl，1991，35： S34-S39.
|
| [18] |
Kidney Disease： Improving Global Outcomes （ KDIGO ）Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases [J]. Kidney Int，2021，100（4S）： S1-S276.
|
| [19] |
刘玉梅，汪年松. 规范乙型肝炎病毒相关性肾小球肾炎的诊断和治疗[J]. 临床肾脏病杂志，2014，14（4）：249-252.
|
| [20] |
王海燕，赵明辉. 肾脏病学（4 版）[M]. 北京： 人民卫出版社，2020：1621.
|
| [21] |
Li D，Gao G，Jiang H，et al. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients [J].Eur J Gastroenterol Hepatol，2015，27（1）：65-69.
|
| [22] |
Nguyen MH，Wong G，Gane E，et al. Hepatitis B virus：advances in prevention，diagnosis，and therapy [ J]. Clin Microbiol Rev，2020，33（2）：19-46.
|
| [23] |
Xu F，Wang C，Shi X，et al. Resolution of HBV infection occurs sooner than recovery of renal disease in adult serum HBsAgnegative HBV-associated glomerulonephritis [J]. J Med Virol，2018，90（9）：1503-1507.
|
| [24] |
Lai FM，Li PK，Suen MW，et al. Crescentic glomerulonephritis related to hepatitis B virus [J]. Mod Pathol，1992，5（3）：262-267.
|
| [25] |
Berchtold L，Zanetta G，Dahan K，et al. Efficacy and safety of rituximab in hepatitis B virus-associated PLA2R-positive membranous nephropathy [J]. Kidney Int Rep，2017，3（2）：486-491.
|